- Curtiss-Wright Corp. (NYSE:CW) has been selected by Airbus SE (OTC:EADSY) to provide custom electric actuation technology for the Main Deck Cargo Door on the future A350F freighter aircraft. Financial terms were not disclosed.
- The A350F, a variant of the Airbus A350, will be the first wide-body freighter aircraft built with a majority of composite materials.
- Curtiss-Wright will provide Airbus with an electro-mechanical actuation solution that features rotary and linear actuators, alongside control and power electronics, to open, close, latch and lock the A350F’s Main Deck Cargo Door.
- The products will be shipped to Airbus in different European facilities. Curtiss-Wright designs and manufactures its electric actuation products at its Shelby, N.C. and Stratford, Ontario facilities.
- Price Action: CW shares are trading higher by 1.24% at $130.43 on the last check Monday.
Horizon Therapeutics Receives FDA Approval For Uncontrolled Gout Candidate
The U.S. Food and Drug Administration (FDA) has approved Horizon Therapeutics’ (NASDAQ: HZNP) supplemental Biologics License Application (sBLA) for expanding the labeling to include KRYSTEXXA (pegloticase) injection co-administered with methotrexate, in patients with uncontrolled gout.
